Skip to main content
NXGL logo

NXGL · Nexgel, Inc. · Financials

Track NXGL — free
$4.05 -0.21 (-4.82%) Q3 2025 earnings call transcript
Market Cap
$2.07M
Shares
487,383
Volume · Oct 28 50.41K Avg daily vol (12 sessions) 347.5K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$11.42M +31.5%
FY2025 Revenue FY2018–FY2025
Net Income
-$3M +8.6%
FY2025 Net Income FY2018–FY2025
Gross Margin
39.48% +7.8pp
FY2025 Gross Margin FY2018–FY2025
Operating Margin
-29.35% +11.6pp
FY2025 Operating Margin FY2018–FY2025
Diluted EPS
-$7.60 +24%
FY2025 Diluted EPS FY2018–FY2025
Operating Cash Flow
-$1.31M +66.1%
FY2025 Operating Cash Flow FY2018–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
$12.07M $11.42MG $8.69M $4.09M $2.05M $1.55M $674K $717K $2.21M
$7.83M $6.91M $5.94M $3.72M $1.79M $1.54M $965K $854K $1.7M
$4.23M $4.51M $2.75M $374K $256K $8000 -$291K -$137K $514K
— 39.48% 31.63% 9.15% 12.5% 0.52% -43.18% -19.11% 23.23%
— $2000 $78K $103K $367K $31K — — —
$9.61M $7.86M $6.22M $3.75M $3.24M $2.55M $1.97M $1.79M $2.4M
$889K $126K $119K $94K $13K — — — —
$1.15M $450K $436K $226K $112K $113K $50K $67K $322K
$9.64M $7.86M $6.3M $3.85M $3.6M $2.58M $1.97M $1.79M $2.4M
-$5.4M -$3.35M -$3.55M -$3.48M -$3.35M -$2.57M -$2.26M -$1.92M -$1.89M
— -29.35% -40.91% -85.03% -163.48% -165.7% -335.31% -268.34% -85.31%
-$4.25M -$2.9M -$3.12M -$3.25M -$3.24M -$2.46M -$2.21M -$1.86M -$1.57M
— $34K $81K $15K $1.34M — — — —
-$650K $459K $91K $289K -$1.4M -$1.74M -$4000 $1000 —
-$6.05M -$2.89M -$3.46M -$3.19M -$4.75M — — — —
— — — — $0 $0 $0 $0 —
-$6.22M -$3M -$3.28M -$3.16M -$4.75M -$4.31M -$2.26M -$1.92M -$1.89M
— -26.27% -37.76% -77.21% -231.74% -277.89% -335.91% -268.2% -85.31%
$133K $107K -$182K -$31K — — — — —
USD/shares -$14.20 -$7.60 -$10.00 -$11.20 -$17.00 -$29.00 -$21.00 -$2.80 -$7.60
USD/shares -$14.20 -$7.60 -$10.00 -$11.20 -$17.00 -$29.00 -$21.00 -$2.80 -$7.60
shares — 392.71K 325.58K 283.59K 278.74K 149K 112.71K 678.53K 250.26K
shares — 392.71K 325.58K 283.59K 278.74K 149K 112.71K 678.53K 250.26K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of notes payable 2026-06-30 USD 102,000 10-Q filed 2026-08-17
Finance lease liabilities 2026-06-30 USD 275,000 10-Q filed 2026-08-17
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 68,000
Noncurrent finance lease liabilities
USD 203,000
Noncurrent convertible debt 2026-06-30 USD 3,054,000 10-Q filed 2026-08-17
Noncurrent notes payable 2026-06-30 USD 437,000 10-Q filed 2026-08-17
Operating lease liabilities 2026-06-30 USD 3,594,000 10-Q filed 2026-08-17
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 747,000
Noncurrent operating lease liabilities
USD 2,847,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Medical Instruments & Supplies median 2.84×
EV/EBIT
—
Medical Instruments & Supplies median 29.94×
P/E (TTM)
—
Medical Instruments & Supplies median 31.29×

Valuation over time computed as of each quarter's filing date

Key facts CIK 1468929 CUSIP 65344E107 Visit website